Arthur Suckow

Arthur Suckow, Ph.D. possesses extensive experience in the biotechnology and pharmaceuticals sectors, currently serving as an advisor at Transcera and Actio Biosciences, Inc., and on the Board of Directors for the CMT Research Foundation. In addition, Arthur is an advisor for Palm Therapeutics and has held the position of CEO at DTxPharma from July 2017 to September 2023. Previous roles include contributions to miRNA Therapeutics at Regulus Therapeutics and drug discovery in diabetes at MedImmune and Johnson & Johnson. Arthur's academic background includes a PhD in Biomedical Sciences from UC San Diego School of Medicine and a B.S. in Genetics, Molecular & Cell Biology from the University of Delaware, complemented by postdoctoral research at UC San Diego.